CFDB - Cystic Fibrosis DataBase

at least one term
all terms

Hypertonic saline therapy for cystic fibrosis

HTA -  Health Technology Assessment Report

Details
  • 2009
  • Purins A, Hiller JE

An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic Fibrosis.

NHSEED -  Economic Study or Review

Details
  • 2017
  • Tappenden P

Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data

NHSEED -  Economic Study or Review

Details
  • 2014
  • van der Ploeg CP

Clinical pharmacist impact on care, length of stay, and cost in pediatric cystic fibrosis (CF) patients

NHSEED -  Economic Study or Review

Details
  • 2013
  • Cies JJ

Cost effectiveness of newborn screening for cystic fibrosis: a simulation study

NHSEED -  Economic Study or Review

Details
  • 2013
  • Nshimyumukiza L

The cost effectiveness of dry powder antibiotics for the treatment of pseudomonas aeruginosa in patients with cystic fibrosis (Provisional abstract)

NHSEED -  Economic Study or Review

Details
  • 2013
  • Tappenden P

Cost-effectiveness of carrier screening for cystic fibrosis in Australia.

NHSEED -  Economic Study or Review

Details
  • 2012
  • Norman R

Effects of a supervised, outpatient exercise and physiotherapy programme in children with cystic fibrosis

NHSEED -  Economic Study or Review

Details
  • 2012
  • Urquhart D

A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis

NHSEED -  Economic Study or Review

Details
  • 2012
  • Wells J

Economic impact of tobramycin in patients with cystic fibrosis in a managed care population (Provisional abstract)

NHSEED -  Economic Study or Review

Details
  • 2011
  • Wertz DA